A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.
Fridge-free COVID-19 vaccine candidates offer hope to billions
Two vaccines in early development are stable under high temperatures and could be game changers in global vaccine equity.
IPCC: Climate change widespread, rampant, and intensifying
Major climate change effects are irreversible, though there is still a small window of time to mitigate the worst.
Long COVID appears to be uncommon in children, analysis finds
Data reported through a smartphone app provides the first detailed description of COVID-19 in symptomatic school-aged children.
Pfizer to seek approval for a new COVID-19 booster shot
Citing concern over vaccine efficacy against emerging variants, Pfizer seeks approval for a third booster, but many are not yet convinced it is necessary.
What are mRNA vaccines?
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
A nasal spray to prevent viral infection
A polymer composite spray was shown to not only limit SARS-CoV-2 infection, but also hinders transmission in this proof-of-concept study.
Why is there hype around the Novavax COVID-19 vaccine?
The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
Warmer temperatures lessen COVID-19 spread, but control measures still needed
Study shows that temperature changes have a smaller effect on transmission than policy interventions like lockdowns and social distancing.
Why are antiviral drugs for COVID-19 difficult to find?
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.